Alcon Inc./Fr. ALC
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Alcon Inc.
Alcon Inc. is a global company specializing in eye care products and medical devices, serving the healthcare sector. The company focuses on two main divisions: Surgical and Vision Care. Its Surgical segment offers ophthalmic products such as cataract, retinal, and refractive surgery equipment, while the Vision Care segment provides contact lenses and lens care products. Headquartered in Geneva, Switzerland, Alcon was founded in 1945 as a small ophthalmic shop in Texas and has since expanded its footprint internationally. Alcon benefits from its extensive research and development capabilities, underpinned by a robust portfolio of market-driven innovations aiming to address unmet eye care needs globally.
Ticker
Fr. ALC
Sector
Primary listing
XSWX
Employees
25,000
Headquarters
Geneva, Switzerland
Website
Alcon Inc. Metrics
BasicAdvanced
CHF 27bn
41.78
CHF 1.35
0.70
CHF 0.28
0.50%
Price and volume
Market cap
CHF 27bn
Beta
0.7
52-week high
CHF 73.12
52-week low
CHF 47.80
Average daily volume
1.4m
Dividend rate
CHF 0.28
Financial strength
Current ratio
2.204
Quick ratio
1.221
Long term debt to equity
20.806
Total debt to equity
23.774
Dividend payout ratio (TTM)
20.27%
Interest coverage (TTM)
6.16%
Profitability
EBITDA (TTM)
1,866.938
Gross margin (TTM)
56.14%
Net profit margin (TTM)
7.70%
Operating margin (TTM)
11.99%
Effective tax rate (TTM)
16.94%
Revenue per employee (TTM)
CHF 347,070
Management effectiveness
Return on assets (TTM)
2.54%
Return on equity (TTM)
3.71%
Valuation
Price to earnings (TTM)
41.777
Price to revenue (TTM)
3.218
Price to book
1.24
Price to tangible book (TTM)
6.85
Price to free cash flow (TTM)
21.505
Free cash flow yield (TTM)
4.65%
Free cash flow per share (TTM)
2.614
Dividend yield (TTM)
0.50%
Forward dividend yield
0.50%
Growth
Revenue change (TTM)
7.14%
Earnings per share change (TTM)
-25.90%
3-year revenue growth (CAGR)
6.19%
3-year earnings per share growth (CAGR)
34.16%
3-year dividend per share growth (CAGR)
15.85%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.